Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

210 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology.
Howes OD, McCutcheon R, Agid O, de Bartolomeis A, van Beveren NJ, Birnbaum ML, Bloomfield MA, Bressan RA, Buchanan RW, Carpenter WT, Castle DJ, Citrome L, Daskalakis ZJ, Davidson M, Drake RJ, Dursun S, Ebdrup BH, Elkis H, Falkai P, Fleischacker WW, Gadelha A, Gaughran F, Glenthøj BY, Graff-Guerrero A, Hallak JE, Honer WG, Kennedy J, Kinon BJ, Lawrie SM, Lee J, Leweke FM, MacCabe JH, McNabb CB, Meltzer H, Möller HJ, Nakajima S, Pantelis C, Reis Marques T, Remington G, Rossell SL, Russell BR, Siu CO, Suzuki T, Sommer IE, Taylor D, Thomas N, Üçok A, Umbricht D, Walters JT, Kane J, Correll CU. Howes OD, et al. Among authors: de bartolomeis a. Am J Psychiatry. 2017 Mar 1;174(3):216-229. doi: 10.1176/appi.ajp.2016.16050503. Epub 2016 Dec 6. Am J Psychiatry. 2017. PMID: 27919182 Free PMC article. Review.
Treatment resistant schizophrenia is associated with the worst community functioning among severely-ill highly-disabling psychiatric conditions and is the most relevant predictor of poorer achievements in functional milestones.
Iasevoli F, Giordano S, Balletta R, Latte G, Formato MV, Prinzivalli E, De Berardis D, Tomasetti C, de Bartolomeis A. Iasevoli F, et al. Among authors: de berardis d, de bartolomeis a. Prog Neuropsychopharmacol Biol Psychiatry. 2016 Feb 4;65:34-48. doi: 10.1016/j.pnpbp.2015.08.010. Epub 2015 Aug 25. Prog Neuropsychopharmacol Biol Psychiatry. 2016. PMID: 26320028 Clinical Trial.
Assessing patient-rated vs. clinician-rated adherence to the therapy in treatment resistant schizophrenia, schizophrenia responders, and non-schizophrenia patients.
Iasevoli F, Fagiolini A, Formato MV, Prinzivalli E, Giordano S, Balletta R, De Luca V, de Bartolomeis A. Iasevoli F, et al. Among authors: de luca v, de bartolomeis a. Psychiatry Res. 2017 Mar;249:159-166. doi: 10.1016/j.psychres.2017.01.015. Epub 2017 Jan 7. Psychiatry Res. 2017. PMID: 28104562
Treatment resistant schizophrenia and neurological soft signs may converge on the same pathology: Evidence from explanatory analysis on clinical, psychopathological, and cognitive variables.
de Bartolomeis A, Prinzivalli E, Callovini G, D'Ambrosio L, Altavilla B, Avagliano C, Iasevoli F. de Bartolomeis A, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2018 Feb 2;81:356-366. doi: 10.1016/j.pnpbp.2017.09.002. Epub 2017 Sep 5. Prog Neuropsychopharmacol Biol Psychiatry. 2018. PMID: 28887181 Clinical Trial.
Clinical evaluation of functional capacity in treatment resistant schizophrenia patients: Comparison and differences with non-resistant schizophrenia patients.
Iasevoli F, D'Ambrosio L, Notar Francesco D, Razzino E, Buonaguro EF, Giordano S, Patterson TL, de Bartolomeis A. Iasevoli F, et al. Among authors: de bartolomeis a. Schizophr Res. 2018 Dec;202:217-225. doi: 10.1016/j.schres.2018.06.030. Epub 2018 Jun 20. Schizophr Res. 2018. PMID: 29934250 Clinical Trial.
Evaluation of a few discrete clinical markers may predict categorization of actively symptomatic non-acute schizophrenia patients as treatment resistant or responders: A study by ROC curve analysis and multivariate analyses.
Iasevoli F, Avagliano C, Altavilla B, Barone A, Ciccarelli M, D'Ambrosio L, Notar Francesco D, Razzino E, Fornaro M, de Bartolomeis A. Iasevoli F, et al. Among authors: de bartolomeis a. Psychiatry Res. 2018 Nov;269:481-493. doi: 10.1016/j.psychres.2018.08.109. Epub 2018 Aug 31. Psychiatry Res. 2018. PMID: 30195742
Disease Severity in Treatment Resistant Schizophrenia Patients Is Mainly Affected by Negative Symptoms, Which Mediate the Effects of Cognitive Dysfunctions and Neurological Soft Signs.
Iasevoli F, Avagliano C, Altavilla B, Barone A, D'Ambrosio L, Matrone M, Notar Francesco D, Razzino E, de Bartolomeis A. Iasevoli F, et al. Among authors: de bartolomeis a. Front Psychiatry. 2018 Oct 31;9:553. doi: 10.3389/fpsyt.2018.00553. eCollection 2018. Front Psychiatry. 2018. PMID: 30429802 Free PMC article.
The effect of ethnicity and immigration on treatment resistance in schizophrenia.
Bani-Fatemi A, Tasmim S, Graff A, Gerretsen P, Dada OO, Kennedy JL, Hettige N, Zai C, de Jesus D, de Bartolomeis A, De Luca V. Bani-Fatemi A, et al. Among authors: de jesus d, de luca v, de bartolomeis a. Compr Psychiatry. 2019 Feb;89:28-32. doi: 10.1016/j.comppsych.2018.12.003. Epub 2018 Dec 7. Compr Psychiatry. 2019. PMID: 30579127 Free article.
Treatment-Resistant to Antipsychotics: A Resistance to Everything? Psychotherapy in Treatment-Resistant Schizophrenia and Nonaffective Psychosis: A 25-Year Systematic Review and Exploratory Meta-Analysis.
Polese D, Fornaro M, Palermo M, De Luca V, de Bartolomeis A. Polese D, et al. Among authors: de luca v, de bartolomeis a. Front Psychiatry. 2019 Apr 17;10:210. doi: 10.3389/fpsyt.2019.00210. eCollection 2019. Front Psychiatry. 2019. PMID: 31057434 Free PMC article.
210 results